Kalaris Therapeutics Inc

KLRS | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.22

-$0.02 (-0.77%)

Sep 22, 2026, 2:02 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $70.83M

Enterprise Value $-73.07M

Beta 0.21

Average Volume 204.57K

Shares Outstanding (Diluted) 23.8M

Shares Change YoY 27.25%

Institutional Ownership 78.31%

Exchange NASDAQ

ISIN US4829291065

Price Performance

Price Change 1M -21.3%

Price Change 3M -27.3%

Price Change 6M -46.9%

Price Change YTD -60.8%

Price Change 1Y -26.1%

Price Change 3Y -99.7%

Price Change 5Y -100.0%

1M CAGR (ann.) -20.1%

1Y CAGR (ann.) -26.0%

5Y CAGR (ann.) -80.5%

All-Time CAGR -30.0%

Valuation

PE Ratio -1.61

Forward PE N/A

PEG Ratio -0.01

Forward PEG 0.09

PS Ratio N/A

Forward PS 7.10

PB Ratio 1.23

P/FCF Ratio -1.55

P/Adj. FCF Ratio -1.53

P/OCF Ratio -1.70

EV/Sales N/A

EV/EBIT 1.62

EV/EBITDA 1.62

EV/FCF 1.60

Earnings Yield -62.1%

FCF Yield -64.4%

Adj. FCF Yield -65.3%

Financial Health

Net Cash $143.56M

Total Debt $0

Cash & Short-Term Investments $93.54M

Total Assets $99.54M

Current Ratio 10.98

Quick Ratio 10.98

Debt / Equity Ratio 0.02

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -2.00

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -1.4%

Returns

Return on Assets -44.5%

Return on Equity -71.7%

Return on Invested Capital -52.4%

Return on Capital Employed -52.6%

Return on Tangible Assets -44.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 50.7%

EPS CAGR 5Y 58.3%

EPS CAGR 10Y N/A

FCF CAGR 3Y 25.9%

FCF CAGR 5Y 34.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y -11.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.52

EPS Growth Est (next Q) -18.8%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $15.50

Price Target Upside 376.9%

Cash Flow

Operating Cash Flow $-45.43M

Free Cash Flow $-45.63M

Adj. Free Cash Flow $-46.27M

FCF Per Share -$1.92

OCF Per Share -$1.91

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-20K

Operating Income $-47.76M

EBITDA $-45.1M

Net Income $-44.26M

EPS (Diluted) -$2.02

Revenue / Employee N/A

Profit / Employee $-2.21M

Employees 20